Microdosing ICG for Serial Colonic Perfusion Study During Surgery

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06254833

Enrollment

Registered

2024-02-12

Start date

2023-11-01

Completion date

2024-11-01

Last updated

2024-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perfusion; Complications

Brief summary

using microdosing of ICG vs regular dosing of ICG for perfusion assessment during surgery

Detailed description

Randomized dosing of 7.5mg or 0.75mg of ICG injection during surgery for bowel perfusion assessment using new imaging equipment

Interventions

OTHERmicro dosing of ICG

smaller dose of injection of ICG. All devices used are FDA approved in clinical use.

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* all patient undergoing intestinal resection surgery

Exclusion criteria

* pregnancy, renal insufficiency

Design outcomes

Primary

Measure	Time frame	Description
ability to assess perfusion	up to 30 days post operatively	likert scale evaluation survey performed by surgeon

Countries

United States

Contacts

Primary ContactShanglei Liu

jtt005@health.ucsd.edu(858)249-1837

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026